Ritter Pharms

RTTR NASDAQ
1.000
-0.040
-3.85%
休市 16:00 08/23 EDT
开盘
1.030
昨收
1.040
最高
1.039
最低
0.9900
成交量
9.94万
成交均量(3M)
24.74万
52周最高
2.560
52周最低
0.4700
换手率
1.05%
市值
942.70万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Ritter Pharms RTTR股票价格,Ritter Pharms股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Ritter Pharmaceuticals, Inc. develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Company's segment is focusing on the development and commercialization of RP-G28. The Company conducts human gut health research by exploring metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into applications intended to have impact on a patient's health. The Company's compound, RP-G28, is under development for the treatment of lactose intolerance. The Company has completed a Phase IIa clinical trial of its product candidate, RP-G28, an orally administered oligosaccharide. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon. The Company has not generated any revenues.
展开 >

最近浏览

名称
价格
涨跌幅